1040nok
0,0 %
Date:2024-05-07Time:17:30:00Latest report:Q4-2023List:Oslo GrowthTicker:ABS
Market Cap:264 mnokEnterprise Value:186 mnokNet Sales:33,8 mnokEarnings:-45,5 mnokEmployees:0ISIN:NO0010859580
Ratios
10-year key figure history for Arctic Bioscience turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Arctic Bioscience with index and moving average MA50 and MA200.
Stockprice:10,40
MA50:9,89
MA200:9,62
Price/MA200:8,1 %
RSI (14):57,3
Price/MA50:5,1 %
Description
Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand. The company operates in Norway, Europe, Australia and APAC.